About Orphan Insight

Further Background

Mark has had major involvement with commissioning structures and HTA bodies including previous experience working with:

  • National Specialised Commissioning Advisory Group
  • National Specialised Commissioning Group
  • Advisory Group for National Specialised Services
  • NICE Highly Specialised Technology programme
  • NHS England Specialised Services Group
  • NHS England Clinical Priorities Advisory Group
  • Public Health England
  • Rare Diseases Advisory Group

Additional involvement spans the remainder of key HTA and commissioning groups across the UK and Ireland including:

  • Scottish Medicines Consortium
  • National Services Division Scotland
  • All Wales Medicines Strategy Group
  • National Centre for Pharmacoeconimics (Ireland)
  • Irish Health Service Executive

Please contact us for further information.